115 related articles for article (PubMed ID: 3563255)
21. Influence of food on steady state serum concentrations of theophylline from two controlled-release preparations.
Lefebvre RA; Belpaire FM; Bogaert MG
Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):375-9. PubMed ID: 3220610
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
Trnavská Z; Vondra V; Elis J
Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
[TBL] [Abstract][Full Text] [Related]
23. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
Schulz HU; Steinijans VW; Gabel H
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis.
van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):569-73. PubMed ID: 3023243
[TBL] [Abstract][Full Text] [Related]
25. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
26. A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis.
Jenkins PF; White JP; Jariwalla AJ; Anderson G; Campbell IA
Br J Dis Chest; 1982 Jan; 76(1):57-60. PubMed ID: 7037034
[TBL] [Abstract][Full Text] [Related]
27. Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo.
Van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):638-42. PubMed ID: 3025113
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility of the single point method for theophylline maintenance dose prediction.
Abad J; Pastor A; Prieto L; Palop J; Jiménez Torres V; Castro J
Allergol Immunopathol (Madr); 1987; 15(6):355-9. PubMed ID: 3445876
[TBL] [Abstract][Full Text] [Related]
29. [Effect of slow-release theophylline on airway inflammation in bronchial asthma].
Adachi M; Minoguchi K; Mita S; Kokubu F; Suzuki H; Sano Y; Akiyama K; Yasuhara H
Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114
[TBL] [Abstract][Full Text] [Related]
30. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
Hirsch H
Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of a new sustained-release formulation of theophylline sodium glycerinate in healthy subjects with a new asymmetric dosage regimen.
Wang P; Qi M; Zhong D; Fang L
Biomed Chromatogr; 2003 Jan; 17(1):58-61. PubMed ID: 12583008
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic study of controlled-release choline theophyllinate in elderly patients.
Mondal BK; Beck PR; Gregory J; le Cotonnec JY; Clarke I
Br J Clin Pract; 1990 Jun; 44(6):223-5. PubMed ID: 2206815
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
Okuma M; Iikura Y
Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (theolair and Theolair retard) in normals and asthmatics. Part I: pharmacokinetics.
Utama I; Kreukniet J; Meering PG; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):287-91. PubMed ID: 6885202
[TBL] [Abstract][Full Text] [Related]
36. [A case of sustained-release theophylline (Theodur)-induced asthma].
Suenaga N; Nakamura H; Kurusu M; Nishioka Y; Kitada O; Sugita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Nov; 29(11):1495-8. PubMed ID: 1770692
[TBL] [Abstract][Full Text] [Related]
37. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
Götz J; Sauter R; Steinijans VW; Jonkman JH
Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of an ultralong sustained-release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: monitoring implications.
Armijo JA; Sánchez BM; Peralta FG; González-Ruiz M; Cuadrado A; Verdejo A; Cos MA; Arjona R
Biopharm Drug Dispos; 2003 May; 24(4):165-71. PubMed ID: 12698500
[TBL] [Abstract][Full Text] [Related]
39. [The effect of protheo on pulmonary function and the change of its plasma concentration in patients with chronic asthmatic bronchitis].
Li S; Chen Y; Tan P
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):299-300. PubMed ID: 10374457
[TBL] [Abstract][Full Text] [Related]
40. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
Arbab OA; Wiggins J; Ayres JG; Stableforth DE
Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
